Salt-Dependent Aquagenic Urticaria, Challenge Test, and Histological Features: Case Report.

Abstract

J Investig Allergol Clin Immunol 2022; Vol. 32(3): 224-240 © 2022 Esmon Publicidad 8. Guillén D, Bobolea I, Calderon O, Fiandor A, Cabañas R, Heredia R, et al. Aspirin desensitization achieved after omalizumab treatment in a patient with aspirin-exacerbated urticaria and respiratory disease. J Investig Allergol Clin Immunol. 2015;25(2):133-5. 9. Namazy JA, Blais L, Andrews EB, Scheuerle AE, Cabana MD, Thorp JM, et al. Pregnancy outcomes in the omalizumab pregnancy registry and a disease-matched comparator cohort. J Allergy Clin Immunol. 2020 Feb 1;145(2):528-36.e1. 10. Breslow RG, Caiado J, Castells MC. Acetylsalicylic acid and montelukast block mast cell mediator-related symptoms during rapid desensitization. Ann Allergy Asthma Immunol. 2009;102(2):155-60.